SION Sionna Therapeutics, Inc. - Common Stock
$5,82
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$4–$55
4% of range
Analystenbewertung
STRONG BUY
17 analysts
Kursziel
$15
+161% upside
P/E (TTM)
-3.1
ROE
-23.4%
Nettogewinnmarge
—
SION Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.82
Marktkapitalisierung
$262M
P/E (TTM)
-3.1
EPS (TTM)
$-1.88
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-23.4%
Verschuldungsgrad
—
52W-Spanne
$4 – $55
SION Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-1.88
2024-12-31
→
2025-12-31
Freier Cashflow
$-67M
2025-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
SION
Peer-Median
P/E (TTM)
-3.1
—
P/B (K/B)
0.9
1.0
Price / FCF (Kurs / FCF)
-3.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
SION
Peer-Median
ROA
-29.4%
-40.4%
ROE
-23.4%
-43.7%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
SION
Peer-Median
Current Ratio (Liquiditätsgrad)
20.6
7.3
Quick Ratio
5.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
SION
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
SION
Peer-Median
SION Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 7 41,2%
- Kauf 7 41,2%
- Halten 2 11,8%
- Verkauf 1 5,9%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
6 Analysten · 2026-08-18
Median
$5.50
Mittelwert
$15.17
Jetzt
$5.82
Tief
$5.00
Hoch
$63.00
Median-Ziel
$5.50
-5,5%
Mittelwert-Ziel
$15.17
+160,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.66 | $-0.66 | 0.00% |
| 31. März 2026 | $-0.60 | $-0.52 | -0.08% |
| 31. Dezember 2025 | $-0.46 | $-0.55 | 0.09% |
| 30. September 2025 | $-0.46 | $-0.49 | 0.03% |
| 30. Juni 2025 | $-0.41 | $-0.57 | 0.16% |
| 31. März 2025 | $-0.62 | $-0.46 | -0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| SRZN | — | — | — | — | — | — |
| ZSQR | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $60M | $57M | |
| SG&A Expense | $29M | $13M | |
| Operating Expenses | $89M | $71M | |
| Operating Income | $-89M | $-71M | |
| Interest Income | $13M | $8M | |
| Other Non-op | $14M | $9M | |
| Income Tax | $0 | $0 | |
| Net Income | $-75M | $-62M | |
| EPS (Basic) | $-1.88 | $-15.99 | |
| EPS (Diluted) | $-1.88 | $-15.99 | |
| Shares (Basic) | 39,962,163 | 3,858,859 | |
| Shares (Diluted) | 39,962,163 | 3,858,859 | |
| EBITDA | $-89M | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $58M | $38M | |
| Prepaid Expense | $6M | $3M | |
| Current Assets | $241M | $151M | |
| PP&E (Net) | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | |
| Accum. Depreciation | $2M | $2M | |
| Other Non-current Assets | $0 | $3M | |
| Total Assets | $326M | $186M | |
| Accrued Liabilities | $10M | $8M | |
| Current Liabilities | $12M | $10M | |
| Capital Leases | $7M | $9M | |
| Total Liabilities | $19M | $19M | |
| Common Stock | $45.0K | $5.0K | |
| Paid-in Capital | $563M | $17M | |
| Retained Earnings | $-256M | $-181M | |
| AOCI | $540.0K | $368.0K | |
| Stockholders' Equity | $307M | $-164M | |
| Liabilities + Equity | $326M | $186M | |
| Shares Outstanding | 44,723,585 | 4,722,763 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $4M | |
| Operating Cash Flow | $-66M | $-53M | |
| CapEx | $377.0K | $27.0K | |
| Investing Cash Flow | $-119M | $-127M | |
| Financing Cash Flow | $206M | $179M | |
| Net Change in Cash | $21M | $-733.0K | |
| Free Cash Flow | $-67M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -29.4% | · | |
| ROE | -23.4% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 20.6 | · | |
| Quick Ratio | 5.0 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-75M | $-62M | |
| Market Cap | $1.84B | · | |
| P/E | -21.9 | · | |
| P/B | 6.0 | · | |
| P / Tangible Book | 6.0 | · | |
| P / Cash Flow | -27.8 | · | |
| P / FCF | -27.6 | · | |
| Earnings Yield | -4.6% | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $22M | $19M | $15M | $16M | $15M | $14M | $14M | |
| SG&A Expense | $11M | $11M | $8M | $8M | $7M | $6M | $4M | |
| Operating Expenses | $32M | $30M | $24M | $24M | $22M | $20M | $18M | |
| Operating Income | $-32M | $-30M | $-24M | $-24M | $-22M | $-20M | $-18M | |
| Interest Income | $3M | $3M | $3M | $3M | $4M | $3M | $2M | |
| Other Non-op | $3M | $3M | $3M | $4M | $4M | $3M | $2M | |
| Net Income | $-30M | $-27M | $-20M | $-20M | $-18M | $-16M | $-16M | |
| EPS (Basic) | $-0.66 | $-0.60 | $1028.58 | $-0.46 | $-0.41 | $-0.62 | $6539.68 | |
| EPS (Diluted) | $-0.66 | $-0.60 | $1028.58 | $-0.46 | $-0.41 | $-0.62 | $6539.68 | |
| Shares (Basic) | 45,148,971 | 44,921,984 | -75,005,946 | 44,255,053 | 44,116,997 | 26,596,059 | -6,869,404 | |
| Shares (Diluted) | 45,148,971 | 44,921,984 | -75,005,946 | 44,255,053 | 44,116,997 | 26,596,059 | -6,869,404 | |
| EBITDA | $-32M | $-30M | · | $-24M | $-22M | $-20M | · |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $63M | $58M | $51M | $41M | $83M | $38M | |
| Prepaid Expense | $5M | $5M | $6M | $4M | $4M | $4M | $3M | |
| Current Assets | $216M | $221M | $241M | $252M | $267M | $274M | $151M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $594.0K | $585.0K | $0 | $0 | $0 | $0 | $3M | |
| Total Assets | $283M | $305M | $326M | $339M | $352M | $370M | $186M | |
| Accrued Liabilities | $9M | $6M | $10M | $7M | $5M | $3M | $8M | |
| Current Liabilities | $11M | $10M | $12M | $10M | $8M | $10M | $10M | |
| Capital Leases | $7M | $7M | $7M | $8M | $8M | $8M | $9M | |
| Total Liabilities | $17M | $17M | $19M | $18M | $16M | $18M | $19M | |
| Common Stock | $45.0K | $45.0K | $45.0K | $44.0K | $44.0K | $44.0K | $5.0K | |
| Paid-in Capital | $579M | $571M | $563M | $557M | $552M | $549M | $17M | |
| Retained Earnings | $-313M | $-283M | $-256M | $-236M | $-216M | $-198M | $-181M | |
| AOCI | $-448.0K | $-84.0K | $540.0K | $420.0K | $183.0K | $301.0K | $368.0K | |
| Stockholders' Equity | $266M | $288M | $307M | $322M | $336M | $352M | $-164M | |
| Liabilities + Equity | $283M | $305M | $326M | $339M | $352M | $370M | $186M | |
| Shares Outstanding | 45,164,239 | 45,075,651 | 44,723,585 | 44,463,527 | 44,132,338 | 44,092,117 | 4,722,763 |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $4M | $3M | $3M | $2M | $1M | |
| Operating Cash Flow | $-22M | $-22M | $-17M | $-15M | $-18M | $-16M | $-12M | |
| CapEx | $0 | $0 | $204.0K | $87.0K | $0 | $86.0K | $27.0K | |
| Investing Cash Flow | $21M | $25M | $23M | $23M | $-23M | $-141M | $15M | |
| Financing Cash Flow | $749.0K | $2M | $2M | $2M | $-312.0K | $202M | $-1M | |
| Net Change in Cash | $-2.0K | $5M | $8M | $10M | $-42M | $45M | $2M | |
| Free Cash Flow | · | $-22M | · | · | · | $-16M | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| ROA | -9.4% | -7.9% | · | -11.9% | -10.3% | -8.9% | · | |
| ROE | -9.9% | -8.4% | · | -12.6% | -10.7% | -9.4% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.0 | 22.6 | · | 25.6 | 35.3 | 28.7 | · | |
| Quick Ratio | 5.9 | 6.5 | · | 5.2 | 5.4 | 8.7 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-95M | $-82M | · | $-80M | $-69M | $-62M | · | |
| Market Cap | $1.99B | $1.81B | · | $1.31B | $766M | $461M | · | |
| P/E | -20.7 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | |
| P/B | 7.5 | 6.3 | · | 4.1 | 2.3 | 1.3 | · | |
| P / Tangible Book | 7.5 | 6.3 | · | 4.1 | 2.3 | 1.3 | · | |
| P / Cash Flow | · | -82.7 | · | · | · | -28.3 | · | |
| P / FCF | · | -82.7 | · | · | · | -28.2 | · | |
| Earnings Yield | -4.8% | -1026.9% | · | -3523.0% | -21588.9% | -68601.1% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Nettoergebnis | $-75M | $-62M |
| Verwässerte EPS | $-1.88 | $-15.99 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 20.6 | — |
| Quick Ratio | 5.0 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-67M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 158 Einreicher · $2.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 49 (+21 vs. Vorquartal) | 6 (-4 vs. Vorquartal) | 49 (+12 vs. Vorquartal) | 36 (+8 vs. Vorquartal) | +3.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $435.722.930 | 9.905.045 | 21,94% | Aktien |
| TPG GP A, LLC | $285.713.378 | 6.494.962 | 14,39% | Aktien |
| VIKING GLOBAL INVESTORS LP | $140.556.012 | 3.195.181 | 7,08% | Aktien |
| Atlas Venture Life Science Advisors, LLC | $131.776.532 | 2.995.602 | 6,64% | Aktien |
| ORBIMED ADVISORS LLC | $112.433.029 | 2.555.877 | 5,66% | Aktien |
| ENAVATE SCIENCES GP, LLC | $109.008.540 | 2.478.030 | 5,49% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $70.384.000 | 1.600.000 | 3,54% | Aktien |
| JENNISON ASSOCIATES LLC | $51.562.131 | 1.172.133 | 2,60% | Aktien |
| CITADEL ADVISORS LLC | $50.143.057 | 1.139.874 | 2,52% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.796.724 | 1.132.001 | 2,51% | Aktien |
| STATE STREET CORP | $44.937.281 | 1.021.534 | 2,26% | Aktien |
| VANGUARD GROUP INC | $44.053.411 | 1.070.817 | 2,22% | Aktien |
| PERCEPTIVE ADVISORS LLC | $39.810.950 | 905.000 | 2,00% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $29.953.495 | 680.916 | 1,51% | Aktien |
| Siren, L.L.C. | $26.856.555 | 610.515 | 1,35% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $20.894.402 | 474.981 | 1,05% | Aktien |
| Casdin Capital, LLC | $17.596.000 | 400.000 | 0,89% | Aktien |
| BAKER BROS. ADVISORS LP | $17.596.000 | 400.000 | 0,89% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $17.528.912 | 398.380 | 0,88% | Aktien |
| Driehaus Capital Management LLC | $16.955.814 | 385.447 | 0,85% | Aktien |
| GOLDMAN SACHS GROUP INC | $16.100.032 | 365.993 | 0,81% | Aktien |
| FRANKLIN RESOURCES INC | $12.762.071 | 290.113 | 0,64% | Aktien |
| Aberdeen Group plc | $12.499.231 | 284.138 | 0,63% | Aktien |
| FMR LLC | $12.242.065 | 278.292 | 0,62% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $12.173.485 | 276.733 | 0,61% | Aktien |
| Candriam S.C.A. | $10.248.950 | 233.208 | 0,52% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.807.527 | 222.949 | 0,49% | Aktien |
| Kalehua Capital Management LLC | $8.669.197 | 197.072 | 0,44% | Aktien |
| Longaeva Partners L.P. | $8.637.524 | 196.352 | 0,43% | Aktien |
| Artisan Partners Limited Partnership | $8.336.017 | 189.498 | 0,42% | Aktien |
| Ensign Peak Advisors, Inc | $8.117.563 | 184.532 | 0,41% | Aktien |
| Soleus Capital Management, L.P. | $7.816.451 | 177.687 | 0,39% | Aktien |
| Sofinnova Investments, Inc. | $6.353.564 | 144.432 | 0,32% | Aktien |
| Qube Research & Technologies Ltd | $6.172.193 | 140.309 | 0,31% | Aktien |
| Alyeska Investment Group, L.P. | $5.992.406 | 136.222 | 0,30% | Aktien |
| GordonMD Global Investments LP | $5.982.640 | 136.000 | 0,30% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.707.834 | 129.753 | 0,29% | Aktien |
| Sio Capital Management, LLC | $5.622.274 | 127.808 | 0,28% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.342.234 | 121.442 | 0,27% | Aktien |
| Artia Global Partners LP | $5.267.407 | 119.741 | 0,27% | Aktien |
| UBS Group AG | $5.111.902 | 116.206 | 0,26% | Aktien |
| First Turn Management, LLC | $4.860.587 | 110.493 | 0,24% | Aktien |
| CITIGROUP INC | $4.799.265 | 109.099 | 0,24% | Aktien |
| Ikarian Capital, LLC | $4.728.925 | 107.500 | 0,24% | Verkaufsoption |
| Rock Springs Capital Management LP | $4.373.882 | 99.429 | 0,22% | Aktien |
| Walleye Capital LLC | $4.282.295 | 97.347 | 0,22% | Aktien |
| Rhenman & Partners Asset Management AB | $4.271.429 | 97.100 | 0,22% | Aktien |
| D. E. Shaw & Co., Inc. | $3.998.779 | 90.902 | 0,20% | Aktien |
| AMERIPRISE FINANCIAL INC | $3.617.386 | 82.232 | 0,18% | Aktien |
| Integral Health Asset Management, LLC | $3.299.250 | 75.000 | 0,17% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.272.636 | 74.395 | 0,16% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $2.778.232 | 63.156 | 0,14% | Aktien |
| STEMPOINT CAPITAL LP | $2.614.150 | 59.426 | 0,13% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $2.199.500 | 50.000 | 0,11% | Aktien |
| Point72 Asset Management, L.P. | $2.169.939 | 49.328 | 0,11% | Aktien |
| TD Asset Management Inc | $2.084.950 | 47.396 | 0,10% | Aktien |
| ALPS ADVISORS INC | $2.002.645 | 45.525 | 0,10% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.868.607 | 42.478 | 0,09% | Aktien |
| XTX Topco Ltd | $1.675.843 | 38.096 | 0,08% | Aktien |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $1.582.232 | 35.968 | 0,08% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.558.126 | 35.420 | 0,08% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.429.675 | 32.500 | 0,07% | Verkaufsoption |
| BNP PARIBAS FINANCIAL MARKETS | $1.399.014 | 31.803 | 0,07% | Aktien |
| Ishara Investments LP | $1.350.540 | 123.000 | 0,07% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.258.114 | 28.600 | 0,06% | Verkaufsoption |
| Swiss National Bank | $1.187.730 | 27.000 | 0,06% | Aktien |
| Quadrature Capital Ltd | $1.144.752 | 26.023 | 0,06% | Aktien |
| MORGAN STANLEY | $1.140.617 | 25.929 | 0,06% | Aktien |
| Trexquant Investment LP | $1.047.402 | 23.810 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.037.548 | 23.586 | 0,05% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.020.291 | 25.450 | 0,05% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $993.074 | 22.575 | 0,05% | Aktien |
| RHUMBLINE ADVISERS | $981.362 | 22.309 | 0,05% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $879.800 | 20.000 | 0,04% | Kaufoption |
| Maven Securities LTD | $879.800 | 20.000 | 0,04% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $820.193 | 18.645 | 0,04% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $793.316 | 18.034 | 0,04% | Aktien |
| Rafferty Asset Management, LLC | $791.996 | 18.004 | 0,04% | Aktien |
| Shay Capital LLC | $791.820 | 18.000 | 0,04% | Aktien |
| Engineers Gate Manager LP | $686.376 | 15.603 | 0,03% | Aktien |
| BlackRock, Inc. | $576.269 | 13.100 | 0,03% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $555.198 | 12.621 | 0,03% | Aktien |
| MARSHALL WACE, LLP | $554.230 | 12.599 | 0,03% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $515.651 | 11.722 | 0,03% | Aktien |
| MetLife Investment Management, LLC | $482.658 | 10.972 | 0,02% | Aktien |
| Bank of New York Mellon Corp | $476.500 | 10.832 | 0,02% | Aktien |
| Jump Financial, LLC | $460.708 | 10.473 | 0,02% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $419.445 | 9.535 | 0,02% | Aktien |
| PROFUND ADVISORS LLC | $402.069 | 9.140 | 0,02% | Aktien |
| Virtus Investment Advisers, LLC | $400.705 | 9.109 | 0,02% | Aktien |
| Russell Investments Group, Ltd. | $395.118 | 8.982 | 0,02% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $373.519 | 8.491 | 0,02% | Aktien |
| CITADEL ADVISORS LLC | $369.516 | 8.400 | 0,02% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $356.319 | 8.100 | 0,02% | Kaufoption |
| Vanguard Global Advisers, LLC | $345.409 | 7.852 | 0,02% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $338.723 | 7.700 | 0,02% | Verkaufsoption |
| Invesco Ltd. | $321.919 | 7.318 | 0,02% | Aktien |
| China Universal Asset Management Co., Ltd. | $316.112 | 7.186 | 0,02% | Aktien |
| Quarry LP | $296.933 | 6.750 | 0,01% | Aktien |
| VARCOV Co. | $282.328 | 6.418 | 0,01% | Aktien |
Unternehmensinsider 12 Insider · 4 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Cloonan | President & CEO | 6. Februar 2025 A | — | 0 | 0 | $0 |
| Elena Ridloff | CFO & Head of Corp. Dev. | 6. Februar 2025 A | — | 0 | 0 | $0 |
| Jennifer Fitzpatrick | Chief Legal Officer | 6. Juli 2026 M | 0 | 0 | 1 | $-446.900 |
| Charlotte Mckee | Chief Medical Officer | 6. Februar 2025 A | — | 0 | 0 | $0 |
| Peter A. Thompson | Direktor | 7. Juli 2026 S | 2.469.959 | 0 | 20 | $-55.674.636 |
| Marcella K. Ruddy | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Harold Edward Fleming | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Joanne L. Viney | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Joshua Resnick | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Laurie Stelzer | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Bruce Booth | Direktor | 17. Juni 2026 A | 807.727 | 0 | 0 | $0 |
| Paul J Clancy | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC ×2 Einreichungen | 20. April 2026 | 6,60% | Änderung | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund III, L.P. ×2 Einreichungen | 7. November 2025 | 22,60% | Änderung | — | SEC |
| Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC ×2 Einreichungen | 20. Oktober 2025 | 5,40% | Änderung | — | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried | 18. Februar 2025 | 15,20% | Erste Einreichung | — | SEC |
| Enavate Sciences GP, LLC, Sionna Aggregator, LP | 18. Februar 2025 | 5,60% | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 32 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1,23% | 46.379 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 6.453 NS | 30. April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,42% | 1.201 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,18% | 23.827 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,16% | 1.066 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 2.455 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 55.058 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,10% | 193.943 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,10% | 1.651 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,06% | 168.969 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 19.765 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 474.105 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,02% | 4.592 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5.028 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 106.139 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 7.105 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 764 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 854 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 69.810 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 598 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 168.317 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 40.627 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 605 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 828 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 13.843 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 633 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 15 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 21.710 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 4.321 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 7.386 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 934.641 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.360 SH | 8. August 2026 | Täglich |